Advertisement

April 28, 2025

Rampart IC Acquires ClearShield

April 28, 2025—Rampart IC, a developer of radiation shielding for interventional suites, announced the acquisition of ClearShield, manufacturer of lead-free, radiation-attenuating acrylic. Both companies are based in Birmingham, Alabama.

Rampart stated that its products incorporate ClearShield panels, which are engineered using an acrylic formula infused with bismuth, a nontoxic and stable element. ClearShield panels are transparent, ecoconscious, and manufactured entirely in the United States, noted the company.

Together, the Rampart and ClearShield solutions have been validated as safe and effective through multiple randomized clinical studies and hundreds of successful installations worldwide, noted Rampart. This strategic acquisition fortifies Rampart’s supply chain with a critical material component for producing safe, sustainable, radiation protection for health care workers, stated the company.

Advertisement


April 28, 2025

Transverse Raises Financing to Support Clinical Development of Point-Guard Device

April 28, 2025

Solo Pace’s Temporary Pacing System for TAVR Procedures Cleared by FDA